Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of the triple CFTR modulator combination Dirocaftor/Posenacaftor/Nesolicaftor in adults with cystic fibrosis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Dirocaftor/Posenacaftor/Nesolicaftor

Snippet

Sponsor: Kors van der Ent | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED